Archived Insight | August 18, 2020

Endowment Strategies for Higher Education

Higher education is in a financial crisis due to COVID-19. Revenue is down, the fall semester is uncertain and the markets have negatively affected many endowments.

Our nationally recognized investment experts from Segal Marco Advisors share essential insights every institutional investor, CFO, board member and school leader should know about endowment investing during these trying times.

Among other things, they address:

  • Asset allocation and spending rate analysis
  • Prioritizing near term cash and cash flow needs
  • Agile investment policy
  • Manager selection
  • Opportunities for yield and liquidity in an ongoing COVID-19 environment
Endowment Strategies for Higher Education

Explore all COVID-19 information

We're regularly publishing more information on the coronavirus as the situation develops.

Learn More

Learn more from our insights

Asian Female Pharmacist Uses Computer To Check Inventory For A Drug

Designing and Negotiating Affordable Pharmacy Benefits

Learn how health plan sponsors can improve pharmacy benefit value through PBM contracting, formulary management and clinical oversight.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical, Healthcare Cost Management

Read Full Insight

Focused Business Woman Working On Laptop Computer Reading

Many Retirement Plans Must Be Amended by December 31, 2026

Learn which retirement plans must be amended by December 31, 2026 and how SECURE Act discretionary and required amendments differ.

Retirement, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate

Read Full Insight

Man Self Injecting GLP 1 Weight Loss Medication Pen At Home

GLP-1s Have Disrupted the Market for Other Diabetes Drugs

Segal’s SHAPE data shows how rising GLP-1 use coincided with declines in insulin, Metformin and DPP-4 inhibitor use.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.